135 related articles for article (PubMed ID: 24292986)
1. XRCC1 R399Q polymorphism and risk of normal tissue injury after radiotherapy in breast cancer patients.
Zhou Y; Zhou W; Liu Q; Fan Z; Yang Z; Tu Q; Li L; Liu H
Tumour Biol; 2014 Jan; 35(1):21-5. PubMed ID: 24292986
[TBL] [Abstract][Full Text] [Related]
2. XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.
Qin CJ; Xu KW; Chen ZH; Zhai ET; He YL; Song XM
Tumour Biol; 2015 Feb; 36(2):461-6. PubMed ID: 25582318
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
Krivokuca AM; Cavic MR; Malisic EJ; Rakobradovic JD; Kolarevic-Ivankovic D; Tomasevic ZI; Brankovic-Magic MV
Int J Biol Markers; 2016 Jul; 31(3):e258-63. PubMed ID: 26954070
[TBL] [Abstract][Full Text] [Related]
4. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.
Zhang Y; Wang Y; Wu J; Li LJ
Tumour Biol; 2013 Aug; 34(4):2321-7. PubMed ID: 23681796
[TBL] [Abstract][Full Text] [Related]
7. Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.
Raabe A; Derda K; Reuther S; Szymczak S; Borgmann K; Hoeller U; Ziegler A; Petersen C; Dikomey E
Radiat Oncol; 2012 Apr; 7():65. PubMed ID: 22537351
[TBL] [Abstract][Full Text] [Related]
8. Association of XRCC1 variants with acute skin reaction after radiotherapy in breast cancer patients.
Zhou L; Xia J; Li H; Dai J; Hu Y
Cancer Biother Radiopharm; 2010 Dec; 25(6):681-5. PubMed ID: 21204762
[TBL] [Abstract][Full Text] [Related]
9. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.
Giotopoulos G; Symonds RP; Foweraker K; Griffin M; Peat I; Osman A; Plumb M
Br J Cancer; 2007 Mar; 96(6):1001-7. PubMed ID: 17325707
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.
Gao R; Price DK; Dahut WL; Reed E; Figg WD
Cancer Biol Ther; 2010 Jul; 10(1):13-8. PubMed ID: 20495366
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
Moullan N; Cox DG; Angèle S; Romestaing P; Gérard JP; Hall J
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1168-74. PubMed ID: 14652276
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Liu B; Shen T
Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
[TBL] [Abstract][Full Text] [Related]
13. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer.
Chung HH; Kim MK; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2006 Dec; 103(3):1031-7. PubMed ID: 16875718
[TBL] [Abstract][Full Text] [Related]
15. Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk.
Wang R; Zhang Y; Zhang J; Zhi X
Tumour Biol; 2014 Mar; 35(3):1739-43. PubMed ID: 24470137
[TBL] [Abstract][Full Text] [Related]
16. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer.
Bu D; Tomlinson G; Lewis CM; Zhang C; Kildebeck E; Euhus DM
Breast Cancer Res Treat; 2006 Oct; 99(3):257-65. PubMed ID: 16596326
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk.
Lao T; Gu W; Huang Q
Mutagenesis; 2008 Nov; 23(6):523-32. PubMed ID: 18765423
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.
Smith TR; Liu-Mares W; Van Emburgh BO; Levine EA; Allen GO; Hill JW; Reis IM; Kresty LA; Pegram MD; Miller MS; Hu JJ
Carcinogenesis; 2011 Sep; 32(9):1354-60. PubMed ID: 21700777
[TBL] [Abstract][Full Text] [Related]
19. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
Andreassen CN; Alsner J; Overgaard M; Sørensen FB; Overgaard J
Int J Radiat Biol; 2006 Aug; 82(8):577-86. PubMed ID: 16966185
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
